Clinical Trials Browser

Terminated × Radiotherapy × 1 year × Clear all

NCT04902040 2026-04-30

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Phase 1/2 Terminated

19 enrolled 11 charts

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

NCT02562625 2026-04-23

PERM

Phase 2 Terminated

17 enrolled 14 charts

Melanoma

NCT04984343 2026-04-23

FORT

Phase 2 Terminated

Prostatic Neoplasms

NCT01507506 2026-04-14

SPECTRO GLIO

Phase 3 Terminated

Glioblastoma

NCT02819752 2026-04-09

PEACH

Phase 1 Terminated

3 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT06110195 2026-03-31

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00421096 2026-03-13

GEMCOL

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT02439008 2026-03-13

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Phase NA Terminated

DermatologicGastrointestinalGenitourinary

Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Colorectal Neoplasms

NCT05491317 2026-02-19

A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors

Phase 1/2 Terminated

Non-CNS Tumor

NCT05443971 2026-02-06

Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05116254 2026-01-23

SADDRIN-1

Phase 1 Terminated

Sarcoma

NCT04765709 2025-12-16

BRIDGE

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT03107780 2025-11-13

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Phase 1 Terminated

Glioblastoma, Gliosarcoma

NCT04402073 2025-10-23

PersoMed-I

Phase 2 Terminated

Medulloblastoma

NCT05579769 2025-10-02

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

Phase 2 Terminated

3 enrolled 10 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT04473937 2025-09-24

Radiation Post-CAR T in Refractory Lymphoma

Phase NA Terminated

3 enrolled 9 charts

LymphoidOther hematologic neoplasm

Lymphoma, Hematologic Neoplasms

NCT03307759 2025-09-15

SABRseq

Phase 1 Terminated

13 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT06370663 2025-06-25

First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC

Phase 2 Terminated

Gastrointestinal

Cholangiocarcinoma

NCT06140407 2025-06-05

Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Phase 2 Terminated

Lung Neoplasms